X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (8) 8
index medicus (8) 8
apoptosis (7) 7
drug synergism (5) 5
leukemia, lymphocytic, chronic, b-cell - pathology (5) 5
article (4) 4
cancer (4) 4
catechin - analogs & derivatives (4) 4
female (4) 4
hematology (4) 4
leukemia, lymphocytic, chronic, b-cell - drug therapy (4) 4
adult (3) 3
aged (3) 3
antineoplastic agents - pharmacology (3) 3
catechin - pharmacology (3) 3
chronic lymphocytic leukaemia (3) 3
cll (3) 3
leukemia (3) 3
male (3) 3
middle aged (3) 3
oncology (3) 3
treatment outcome (3) 3
akt (2) 2
antineoplastic combined chemotherapy protocols - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
apoptosis - drug effects (2) 2
care and treatment (2) 2
catechin (2) 2
cell line, tumor (2) 2
chronic lymphocytic-leukemia (2) 2
disease-free survival (2) 2
epigallocatechin-3-gallate (2) 2
green tea (2) 2
heterocyclic compounds, 3-ring - administration & dosage (2) 2
leukemia, lymphocytic, chronic, b-cell - enzymology (2) 2
leukemia, lymphocytic, chronic, b-cell - immunology (2) 2
leukemia, lymphocytic, chronic, b-cell - mortality (2) 2
moral education (2) 2
neoplasm staging (2) 2
research (2) 2
rituximab (2) 2
rituximab - administration & dosage (2) 2
survival (2) 2
trial (2) 2
éducation morale (2) 2
67-kda laminin receptor (1) 1
67‐kda laminin receptor (1) 1
abridged index medicus (1) 1
activation (1) 1
acute myeloid-leukemia (1) 1
administration, oral (1) 1
aged, 80 and over (1) 1
akt protein (1) 1
angiogenesis inhibitors - adverse effects (1) 1
angiogenesis inhibitors - therapeutic use (1) 1
animals (1) 1
anticancer properties (1) 1
antigen receptor (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - pharmacokinetics (1) 1
antineoplastic agents, alkylating - pharmacology (1) 1
antineoplastic agents, immunological - adverse effects (1) 1
antineoplastic agents, immunological - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - pharmacology (1) 1
asymptomatic diseases (1) 1
axl (1) 1
b cell receptor (1) 1
b-cell receptor (1) 1
b-lymphocytes (1) 1
bendamustine (1) 1
bendamustine hydrochloride (1) 1
bendamustine hydrochloride - administration & dosage (1) 1
bevacizumab (1) 1
bevacizumab - adverse effects (1) 1
bevacizumab - therapeutic use (1) 1
blotting, western (1) 1
btk (1) 1
catechin - administration & dosage (1) 1
catechin - adverse effects (1) 1
catechin - pharmacokinetics (1) 1
cell biology (1) 1
cell line, tumor - drug effects (1) 1
cell survival (1) 1
cell survival - drug effects (1) 1
cell survival - genetics (1) 1
cell-death (1) 1
cells, cultured (1) 1
character education (1) 1
chemoimmunotherapy (1) 1
chemoprevention (1) 1
chronic lymphatic leukemia (1) 1
chronic lymphocytic leukemia (1) 1
cll b-cells (1) 1
coculture techniques (1) 1
college students (1) 1
colleges & universities (1) 1
consumption (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 236 - 236
Abstract The targeted therapy ibrutinib inhibits B cell receptor signaling (BTK inhibitor) and has yielded high response rates and durable remissions in... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 5538 - 5538
Abstract Background MBL is a precursor state to CLL, with a prevalence of ~5-8% in the general population and 15-18% in CLL families. To date, 41 single... 
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 2016, Volume 7, Issue 48, pp. 78269 - 78280
Journal Article
Blood, ISSN 0006-4971, 11/2009, Volume 114, Issue 22, pp. 3452 - 3452
Abstract Abstract 3452 Poster Board III-340 PURPOSE Chronic Lymphocytic Leukemia (CLL) is incurable with current chemotherapy treatments. Epigallocatechin 3... 
Journal Article
Blood, ISSN 0006-4971, 11/2012, Volume 120, Issue 21, pp. 3927 - 3927
Abstract Abstract 3927 PURPOSE: CLL B-cells interact with their microenvironment in a variety of ways that influence leukemia cell survival. Contact mediated... 
Journal Article
Journal Article
American Journal of Hematology, ISSN 0361-8609, 08/2017, Volume 92, Issue 8, pp. 759 - 763
Journal Article
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 1961 - 1961
Abstract Introduction: We demonstrated that elevated levels ofcirculating microvesicles (MV) in CLL activate CLL bone marrow stromal cells (BMSCs) with... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 4373 - 4373
Abstract Sequencing studies have significantly improved our understanding of the CLL genetic landscape and allowed the identification of the first associations... 
Journal Article
Clinical cancer research : an official journal of the American Association for Cancer Research, ISSN 1078-0432, 5/2015, Volume 21, Issue 9, pp. 2115 - 2126
BTK | Tyro3 | CLL | TP-0903 | Axl
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 1946 - 1946
Abstract Introduction: B-cell chronic lymphocytic leukemia (CLL) is an incurable disease despite that still requires options for treatment despite recent... 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.